Dysferlin promotes inflammatory macrophage responses and modulates Ca 2+ -dependent STAT1 signaling
Life Science Alliance · 2026
DOI: 10.26508/lsa.202603669 ↗Kurz gefasst
Fachartikel in der Zeitschrift Life Science Alliance, 2026. Verfasst von Kana Tominaga und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan kanat@yamaguchi-u.ac.jp. Hauptthemen laut MEDLINE: STAT1 Transcription Factor, Macrophages, Calcium, Dysferlin. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Astellas | Astellas Foundation for Research on Metabolic Disorders, Uehara Memorial Foundation, MEXT | Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Macrophage differentiation and activation shape tissue homeostasis and regeneration. Dysferlin (DYSF) is best known for its role in membrane repair in skeletal muscle, but its function in immune cells remains poorly understood. Here, we identify DYSF as a regulator of inflammatory macrophage–associated activation. DYSF expression increased during monocyte-to-macrophage differentiation. Gain- and loss-of-function analyses revealed that DYSF promoted inflammatory macrophage–associated responses, including cytokine production and migration. DYSF also enhanced Ca 2+ influx and STAT1 Ser727–associated signaling, whereas Dysf knockdown or Ca 2+ entry inhibition suppressed these responses. DYSF expression increased with aging in human CD14-positive cells and mouse monocyte/macrophage-lineage cells, and DYSF-expressing F4/80-positive macrophage-lineage cells accumulated in aged skeletal muscle. In a macrophage–myoblast co-culture system, DYSF-enriched inflammatory macrophages inhibited myogenic differentiation and myotube fusion, with this effect being partially mediated by soluble inflammatory factors, demonstrating an influence of macrophage DYSF on neighboring myogenic cells in vitro. Together, these findings support a role for DYSF in Ca 2+ -dependent STAT1-associated inflammatory responses in macrophages and in the suppression of myogenesis in cellular models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Neuropsychiatry, Department of Neuroscience, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan kanat@yamaguchi-u.ac.jp.
- Division of Clinical Laboratory Sciences, Department of Nursing and Laboratory Science, Yamaguchi University Graduate School of Medicine, Yamaguchi, Japan.
- Division of Advanced Cell Therapy, Yamaguchi University Research Institute for Cell Design Medical Science (RICeD), Yamaguchi, Japan.
ORCID-Profile: Kana Tominaga, Naoomi Tominaga
Förderung
- Astellas | Astellas Foundation for Research on Metabolic Disorders
- Uehara Memorial Foundation
- MEXT | Japan Society for the Promotion of Science
- MEXT | Japan Science and Technology Agency
- Yamaguchi University
- Ministry of Education, Culture, Sports, Science and Technology
Zitieren
APA
Tominaga, K., & Tominaga, N. (2026). Dysferlin promotes inflammatory macrophage responses and modulates Ca 2+ -dependent STAT1 signaling. Life Science Alliance. https://doi.org/10.26508/lsa.202603669
Vancouver
Tominaga K, Tominaga N. Dysferlin promotes inflammatory macrophage responses and modulates Ca 2+ -dependent STAT1 signaling. Life Science Alliance. 2026. doi:10.26508/lsa.202603669
BibTeX
@article{Tominaga2026,
author = {Tominaga, Kana and Tominaga, Naoomi},
title = {Dysferlin promotes inflammatory macrophage responses and modulates Ca 2+ -dependent STAT1 signaling},
journal = {Life Science Alliance},
year = {2026},
doi = {10.26508/lsa.202603669}
}
EUVIMED